Advances on Ethnobotanical, Phytochemical, and Preclinical Studies of Strobilanthes crispus and Strobilanthes cusia (Acanthaceae) for Drug Development Purpose: A Narrative Review

, this plant may be established as a plant-based antimicrobial, anti-inflammatory, anticancer, or hypoglycemic agent, which may be attributed to its indolo-quinazoline alkaloid and flavonoids. Despite promising pharmacological evidence, there are limited human studies during the selected publication period. However, several articles have described ethnopharmacological surveys of medicinal plants in China, Malaysia, and Thailand, which documented the folkloric use of these two plants. It should be taken to notice that the lack of human studies requires further clinical trials to validate pharmacological activity, efficacy, and safety, and confirm its potential as a therapeutic agent.